Compare FMC Corp (FMC) vs CarMax, Inc (KMX) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

CarMax (KMX) stock trades at $59.87, up 7.43% in the last session, with a bullish technical signal from moving averages. The company reported Q1 2026 earnings that beat expectations, with revenue of $26.35 billion and net income of $500.56 million in 2025. However, net income margin remains thin at 0.84%, and the stock trades at a P/E of 36.61, which is elevated relative to historical norms. Recent news highlights a four-pillar strategic turnaround under new CEO Keith Barr, though an ongoing legal investigation adds uncertainty.

The outlook for KMX hinges on successful execution of its growth strategy amid a challenging used car market. Upside potential exists if cost controls and digital initiatives improve profitability, but risks include high debt levels, margin pressure, and the pending legal probe. Analyst consensus is mixed, with a Hold rating predominant and a price target of $48.91 below the current price, suggesting caution despite recent positive momentum.